TY - JOUR
T1 - Recent advances in homogenous immunoassays based on resonance energy transfer
AU - Takkinen, Kristiina
AU - Žvirblienė, Aurelija
PY - 2019/2
Y1 - 2019/2
N2 - Development of homogeneous immunoassays based on Förster resonance energy transfer (FRET), chemiluminescence resonance energy transfer (CRET) or bioluminescence resonance energy transfer (BRET) enables a one-step, rapid and direct detection of analytes as compared to the multistep, time-consuming heterogeneous immunoassays. Antibody fragments such as Fab or F(ab)2 are extensively exploited in both competitive and non-competitive formats to circumvent the size limitations characteristic of full-length antibodies. Semiconductor fluorescent nanocrystals, quantum dots are becoming increasingly popular as energy acceptors due to their beneficial optical properties as compared to organic dyes. These and other technical advances open new ways for using homogenous immunoassays in a variety of bioanalytical applications including detection of protein biomarkers, hormones, drugs of abuse, food and environmental toxins.
AB - Development of homogeneous immunoassays based on Förster resonance energy transfer (FRET), chemiluminescence resonance energy transfer (CRET) or bioluminescence resonance energy transfer (BRET) enables a one-step, rapid and direct detection of analytes as compared to the multistep, time-consuming heterogeneous immunoassays. Antibody fragments such as Fab or F(ab)2 are extensively exploited in both competitive and non-competitive formats to circumvent the size limitations characteristic of full-length antibodies. Semiconductor fluorescent nanocrystals, quantum dots are becoming increasingly popular as energy acceptors due to their beneficial optical properties as compared to organic dyes. These and other technical advances open new ways for using homogenous immunoassays in a variety of bioanalytical applications including detection of protein biomarkers, hormones, drugs of abuse, food and environmental toxins.
UR - http://www.scopus.com/inward/record.url?scp=85050678074&partnerID=8YFLogxK
U2 - 10.1016/j.copbio.2018.07.003
DO - 10.1016/j.copbio.2018.07.003
M3 - Article
AN - SCOPUS:85050678074
SN - 0958-1669
VL - 55
SP - 16
EP - 22
JO - Current Opinion in Biotechnology
JF - Current Opinion in Biotechnology
ER -